Senate President Pro Tempore Dave Sokola passed legislation to help better protect the health and safety of students at colleges and universities throughout the First State.
Passed unanimously by the Senate and the House, Senate Bill 55 allowed Delaware’s institutions of higher learning to acquire and stock epinephrine autoinjectors. Perhaps better known by the brand name EpiPen, epinephrine autoinjectors are used to treat life-threatening allergic reactions to foods, insect stings, medications and other causes.
In addition to increasing the stockpile of available autoinjectors, Senate Bill 55 also requires employees at colleges and universities to complete training in how to recognize the symptoms of severe allergic reactions, how to store and use the autoinjectors, as well as associated risks and other considerations. The bill also exempts people who provide or administer epinephrine from liability.
